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Abstract: The special sense of taste guides and guards food intake and is essential for body
maintenance. Salty and sour tastes are sensed via ion channels or gated ion channels while G
protein-coupled receptors (GPCRs) of the taste receptor type 1 (T1R) family sense sweet and umami
tastes and GPCRs of the taste receptor type 2 (T2R) family sense bitter tastes. T1R and T2R receptors
share similar downstream signaling pathways that result in the stimulation of phospholipase-C-β2.
The T1R family includes three members that form heterodimeric complexes to recognize either amino
acids or sweet molecules such as glucose. Although these functions were originally described in
gustatory tissue, T1R family members are expressed in numerous non-gustatory tissues and are now
viewed as nutrient sensors that play important roles in monitoring global glucose and amino acid
status. Here, we highlight emerging evidence detailing the function of T1R family members in the
musculoskeletal system and review these findings in the context of the musculoskeletal diseases
sarcopenia and osteoporosis, which are major public health problems among the elderly that affect
locomotion, activities of daily living, and quality of life. These studies raise the possibility that T1R
family member function may be modulated for therapeutic benefit.
Keywords: taste receptor; bone; skeletal muscle; sarcopenia; osteoporosis; T1R3; myogenesis;
bone remodeling
1. Introduction
The special sense of taste acts as the guardian and guide for food intake and is essential for body
maintenance [1]. The sensation of taste can be divided into five distinct qualities; salty, sour, bitter,
sweet, and umami [2]. The sensation of bitter and sour tastes deters us from ingesting potential toxic
substances and strong acids while sweet, umami, and salty tastes encourage us to eat foods containing
carbohydrates, amino acids, and sodium, respectively [2]. Salty and sour tastes are transduced via
ion channels or gated ion channels which are expressed in gustatory tissues and in a variety of
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non-gustatory tissues such as the kidney [3]. In contrast, sensing of the remaining tastes relies on two
distinct families of G protein–coupled receptors (GPCRs) named the taste receptor type 1 (T1R) family,
which senses sweet and umami, and the taste receptor type 2 (T2R) family, which senses bitter [4–8].
Although the T1R and T2R receptor families drive different taste sensations, they share similar
downstream signaling pathways wherein receptors are coupled to a heterotrimeric G protein consisting
of α-, β- and γ-subunits. Activation of the T1R or T2R triggers the separation of the α-subunit,
which is commonly α-gustducin, from the β/γ subunits. Downstream events include stimulating
phospholipase C β2 (PLCβ2) and second messengers that consequently increase cytosolic Ca2+
levels to activate the transient receptor potential cation channel M5 (TRPM5) and induce membrane
depolarization and action potential generation [9,10].
The T1R family includes three members, T1R1, T1R2, and T1R3, which form heterodimeric
complexes that exhibit differential recognition of ligands: T1R3 complexes with T1R1 to form the
umami taste receptor, which responds to amino acids, while T1R3 complexes with T1R2 to form the
sweet taste receptor, which responds to molecules such as glucose [7–9,11]. Although these functions
were originally described in and most commonly assigned to gustatory tissue, the first indication
that T1Rs and elements of the taste transduction cascade might exist outside of the mouth was more
than 20 years ago when the expression of the taste signaling–associated G protein α-gustducin was
observed in brush cells of the stomach and intestine [12]. Subsequent studies have demonstrated
the expression of and a functional role for T1R family members in a wide variety of tissues and cell
types such the pancreatic β-cells [13], adipose tissue [14], heart [15], and central nervous system [16].
Thus, despite the name “taste receptor”, these GPCRs are now viewed as “nutrient sensors” that play
important roles in chemoreception to detect global glucose and amino acid status [17].
The function of T1R family members in several non-gustatory systems has been summarized
previously [2,18]. However, we are particularly struck by several recent reports highlighting T1R
family members in the musculoskeletal system [19–22] and wish to briefly review these findings in the
context of the musculoskeletal diseases sarcopenia and osteoporosis, which are major public health
problems among the elderly that affect locomotion, activities of daily living, and quality of life [23].
2. Sarcopenia and the Role of the T1R Family in Myogenesis
Sarcopenia is characterized by an age-related loss of skeletal muscle mass and a decline in muscle
strength that compromises the health span [24]. The prevalence of sarcopenia is approximately 10%
among adults aged 60 or older [25], resulting in a cost over US$18 billion in 2001 alone [26]. Thus, there
is an unmet and urgent need for strategies that will improve skeletal muscle mass and/or function in
aging adults.
Satellite cells are skeletal muscle stem cells that provide a regenerative capacity for skeletal
muscle. Aged skeletal muscle shows a profound regenerative impairment that contributes to physical
incapacitation. Aged skeletal muscles fail to retain stem cell quiescence [27–29] and both the number
and the functionality of muscle stem cells decline with aging [27–32]. The process of autophagy,
which involves the degradation of long-lived proteins and damaged organelles in lysosomes, has
been implicated in the aging of different model organisms [29,33–36]. Recent work indicates that
autophagy maintains the multipotency of satellite cells by preventing senescence [37], indicating that
the appropriate regulation of autophagy is required for the maintenance of skeletal muscle mass
and function. This also raises the possibility that dysregulation of autophagy is involved in the
pathogenesis of sarcopenia.
Differentiation of skeletal muscle fibers—myogenesis—is a complex and tightly regulated process
involving the commitment of mesenchymal stem cells to the myogenic lineage, myoblast proliferation,
and exit from the cell cycle. This multi-step process is orchestrated by a handful of genes encoding the
myogenic regulatory factors (MRFs), which belong to the basic-helix-loop-helix (bHLH) transcription
factor family and consist of Myf5, MyoD, MRF4, and Myogenin. Although genetic models have
shown that MRFs display a certain degree of functional redundancy [38,39], Myf5 and MyoD are
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responsible for myoblast lineage commitment, regulating the formation, proliferation, and longevity
of myoblasts; MRF4 and Myogenin instead play critical roles in the regulation of the final stage of
differentiation [40–42].
We recently reported that MRFs regulate the expression of the bi-functional T1R family member
T1R3: overexpression of MyoD and Myogenin induces murine T1R3 promoter activity and ChIP
analysis demonstrated that MyoD and Myogenin bind to the endogenous murine T1R3 promoter region
and increase mRNA levels of endogenous T1R3 in the murine mesenchymal stem cell line C3H10T1/2,
which has myogenic potential [20]. Comparative and functional genomic results examining
transcription factor binding sites (Table 1) raise the possibility that the cis-regulatory elements by
which MRFs regulate T1R3 expression are conserved across species [20]. These observations are
consistent with the fact that expression levels of T1R3 increase with myogenic differentiation of the
murine myoblast cell line C2C12 and skeletal muscle cell lines [20]; unpublished data from our group
indicates that T1R1 expression also correlates with advanced differentiation during myogenesis (data
not shown). These findings are supported by the findings that T1R1 and T1R3 are endogenously
expressed in the skeletal muscle tissue and that skeletal muscle cells of T1R3 knockout mice exhibit
decreasing activity of mechanistic target of rapamycin complex 1 (MTORC1) and a higher frequency of
autophagy [21,43], suggesting that T1R3 function is critical to detecting nutrient status since skeletal
muscle is the main source of stored amino acid during times of amino acid deprivation [44]. For these
reasons, we hypothesize that reduced signaling through T1R3 is involved in the pathogenesis of
skeletal muscle diseases such as sarcopenia through improper regulation of autophagy.
Table 1. Transcription factor binding sites are conserved between H. sapiens and M. musculus promoter
region. Common transcription factor binding sites upstream of T1R3 were identified using rVista 2.0
for H. sapiens and M. musculus [20].
No. Transcription Factor (Description) No. Transcription Factor (Description)
1 AP2 (activator protein 2) 22 LXR
2 AP2α (activator protein 2α) 23 MAZ
3 AP4 (activator protein 4) 24 MYOD (myoblast determining factor)
4 ATF4 (activating transcription factor 4) 25 MYOGENIN
5 CEBP (CCAAT/enhancer binding protein) 26 NGFIC
6 CHCH (Churchill) 27 R (Epstein-Barr virus transcription factor R)
7 CP2 28 RFX (X-box binding protein RFX)
8 CREB (cAMP-response element-binding protein) 29 SEF1
9 DEAF1 30 SMAD
10 E12 31 SMAD4
11 E2A 32 SP1
12 E2F 33 SPZ1
13 E2F1 34 SREBP1
14 EBOX 35 SRF (serum response factor)
15 EGR 36 SRY (sex-determining region Y gene product)
16 FOXO4 (fork head box O4) 37 STAF (Se-Cys tRNA gene transcription activating factor)
17 HEB 38 STRA13
18 HEN1 39 TEF1
19 HSF1 (heat shock factor 1) 40 UF1H3β
20 KROX 41 USF (upstream stimulating factor)
21 LBP1 42 ZID (zinc finger with interaction domain)
3. Osteoporosis and the Role of the T1R Family in Postnatal Bone Remodeling
Osteoporosis is a skeletal disease characterized by low bone mass and microarchitectural
deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to
fracture [45]. In 2010, more than 10 million Americans over the age of 50 had osteoporosis, with
another 43 million Americans at risk for the disease [46]. It is estimated that greater than 1.5 million
fragility fractures occur each year, with an annual health care cost of at least US$14 billion [47]
and, by 2025, the health care expenditures for osteoporotic fractures will approach US$25.3 billion.
The pathogenesis of osteoporosis is complex, with numerous pathways implicated as playing a role
in regulating bone mass [48]; that said, there is an urgent and unmet need to identify new treatment
targets and strategies for improving bone mass and strength in the aging skeleton.
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The T1R family members T1R2 and T1R3, which heterodimerize to form the sweet taste receptor,
were recently identified as playing a role in the regulation of postnatal bone mass. Global loss of either
T1R2 or T1R3 expression leads to increased cortical bone mass and trabecular remodeling under high
fat conditions with little to no change in glucose tolerance, insulin sensitivity and energy balance [19].
Reduced bone marrow adiposity was observed in these mice and, since bone-forming osteoblasts and
marrow adipocytes are both derived from bone marrow stromal cell (BMSC)s, these authors postulated
that T1R2 and/or T1R3 regulates cell fate determination in the bone marrow microenvironment.
These findings may hold insight into human disease as the balance between adipocyte and osteoblast
differentiation is disrupted in some conditions such that adipocyte differentiation is increased relative
to osteoblast differentiation, leading to a reduction in bone mass, increased bone fragility, and
an increased susceptibility to fracture [49]. The role of T1R family members in bone formation
requires further examination through the BMSC-specific deletion of T1R2 and/or T1R3 mice; however,
conditional alleles are not available at present. Furthermore, it is possible that T1R family members
may regulate bone remodeling via additional mechanisms since bone resorption is markedly reduced
and cortical bone mass is increased in T1R3 knockout mice under standard dietary conditions [49].
4. Conclusions
Recent evidence indicates that T1R family members participate in the regulation of numerous
physiological processes in a wide variety of organ systems [18]. In this brief review, we highlighted the
emerging evidence that T1R family members are members of the endogenous mechanisms that impact
the musculoskeletal system (Figure 1). The studies discussed here raise the possibility that T1R family
member function may be modulated for therapeutic benefit.
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Figure 1. Model for the possible role of T1R family members in the bone marrow and skeletal muscle 
microenvironments. T1R2-T1R3 detects glucose and regulates cell fate determination of bone marrow 
stromal cells (BMSCs), promoting adipocyte (AD) differentiation over osteoblast (OB) differentiation. 
In contrast, T1R1-T1R3 detects amino acids leading to the activation of MTORC1 and inhibition of 
autophagy, in part through the activation of phospholipase C (PLC), increasing intracellular calcium 
and the activation of MAPK1-MAPK3. T1R1-T1R3 is required for the amino acid–induced localization 
of MTOR to the lysosome, which is a necessary step in MTORC1 activation [50]. 
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microenvironments. T1R2-T1R3 detects glucose and regulates cell fate determination of bone marrow
stromal cells (BMSCs), promoting adipocyte (AD) differentiation over osteoblast (OB) differentiation.
In contrast, T1R1-T1R3 detects amino acids leading to the activation of MTORC1 and inhibition of
autophagy, in part through the activation of phospholipase C (PLC), increasing intracellular calcium
and the activation of MAPK1-MAPK3. T1R1-T1R3 is required for the amino acid–induced localization
of MTOR to the lysosome, which is a necessary step in MTORC1 activation [50].
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